What is the appropriate evaluation and management for night sweats in a 43‑year‑old woman with a recently identified ovarian cyst and uterine leiomyoma on ultrasound?

Night Sweats in a 43-Year-Old Woman with Ovarian Cyst and Leiomyoma

The night sweats are almost certainly unrelated to the incidentally found ovarian cyst and leiomyoma, and require a separate, systematic evaluation for other causes including perimenopause, infection, malignancy, and endocrine disorders.

Why the Pelvic Findings Are Likely Incidental

The ovarian cyst and uterine leiomyoma identified on ultrasound are extremely common incidental findings in premenopausal women and do not cause night sweats. Leiomyomas are present in 20-30% of women over age 30 1, and most ovarian cysts in premenopausal women are functional and benign 1. Simple cysts establish a benign process in 98.7% of premenopausal women 1.

Key Point About These Findings:

• Uterine leiomyomas typically cause menstrual abnormalities (heavy bleeding), pelvic pain, or bulk symptoms—not systemic symptoms like night sweats 2
• Ovarian cysts in premenopausal women are usually asymptomatic and functional 1
• Neither condition produces the systemic inflammatory or hormonal response that would cause night sweats

Appropriate Evaluation for Night Sweats

1. Assess Menopausal Status First

At age 43, perimenopause is the most likely cause:

• Check FSH and estradiol levels
• Document menstrual pattern changes
• Ask about other vasomotor symptoms (hot flashes, mood changes)
• Perimenopause can begin in the early-to-mid 40s and commonly causes night sweats

2. Rule Out Serious Causes

Perform targeted evaluation for:

Infectious causes:

• Tuberculosis screening (especially if risk factors present)
• HIV testing
• Endocarditis evaluation if cardiac risk factors

Malignancy screening:

• Complete blood count (lymphoma can present with night sweats)
• Chest X-ray
• Consider CA-125 only if ovarian mass has concerning features on ultrasound (see below)

Endocrine disorders:

• Thyroid function tests (hyperthyroidism)
• Fasting glucose (diabetes)
• Consider pheochromocytoma if hypertension present

3. Characterize the Pelvic Findings Properly

For the ovarian cyst 1, 3:

• If simple cyst <5 cm: no follow-up needed
• If simple cyst >5 cm: single follow-up ultrasound in 8-12 weeks
• If complex features present (solid components, papillary projections, septations >3mm, ascites): apply IOTA Simple Rules or O-RADS classification

Benign features (no further workup needed) 1:

• Unilocular cyst
• Solid components <7mm
• Smooth multilocular appearance
• Diameter <100mm
• No blood flow on Doppler

Concerning features (require further evaluation) 1:

• Irregular solid tumor
• Ascites
• ≥4 papillary structures
• Irregular multilocular-solid tumor
• Very strong blood flow

For the leiomyoma 4:

• Document size, number, and location
• Assess if causing symptoms (heavy bleeding, pelvic pressure, urinary frequency)
• If asymptomatic: no treatment needed
• Transvaginal ultrasound is adequate for follow-up if needed 5

Management Algorithm

1. Immediate: Complete history focusing on B-symptoms (fever, weight loss, night sweats pattern), menstrual history, and infectious exposures

2. Laboratory workup: CBC, FSH/estradiol, TSH, HIV, tuberculosis screening if indicated

3. Imaging: Chest X-ray to evaluate for lymphoma or tuberculosis

4. Pelvic findings:

   • If cyst is simple and <5cm: reassure and no follow-up
   • If cyst >5cm or has any complex features: follow ACR guidelines for characterization 1, 5
   • Leiomyoma requires no intervention unless symptomatic

Critical Pitfall to Avoid

Do not attribute systemic symptoms like night sweats to incidental pelvic findings. This is a common error that delays diagnosis of serious conditions. The temporal relationship and symptom pattern should guide your evaluation—night sweats are a systemic symptom requiring systemic evaluation, while pelvic masses cause local symptoms (pain, bleeding, pressure) 2, 6.

If the ovarian cyst has any concerning features on ultrasound, then CA-125 can be obtained, but remember that CA-125 has poor specificity in premenopausal women due to false positives from endometriosis, functional cysts, and menstruation 6, 7. A CA-125/CEA ratio can help distinguish ovarian from gastrointestinal primary if the mass is truly concerning 7.